Moderna Execs Hyped Ineffective RSV Vax, Suit Says

By Julie Manganis · September 24, 2024, 6:15 PM EDT

Officers and directors of Moderna misled investors about the efficacy of its RSV vaccine, causing share prices to dive when it was revealed in June to have only about a 50%...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Ali v. Bancel et al

Case Number

Court

Massachusetts

Nature of Suit

Securities/Commodities

Date Filed

September 24, 2024

Recent Articles By Julie

December 02, 2024
NY Doctor To Admit Role In Brain Scan Kickback Scheme
December 02, 2024
Ex-Parexel Worker Says Vax Rule Lacked 'Informed Consent'
November 13, 2024
JPMorgan, Health System In Talks To Settle Email Scheme Suit
November 07, 2024
DOL Secretary Seeks Unpaid OT From Health Staffing Cos.
November 06, 2024
Mass. Voters Reject Tipped Minimum Wage Proposal
October 17, 2024
Ex-Genzyme Exec Says Anxiety Disclosure Led To Firing
October 15, 2024
Motley Rice May Avoid DQ In Boston Opioid Case, Judge Hints
October 10, 2024
Teva To Pay $450M To Settle Kickback Cases
October 08, 2024
Mass. Seeks Order Forcing Steward To Maintain Coverage
September 23, 2024
Mass. General Asks Court To End Fat Removal Patent License